日辰股份(603755.SH):融誠吾陽及德潤壹號大宗交易減持1.5%股份
格隆匯9月21日丨日辰股份(603755.SH)公佈,本次股份減持前,福建融誠吾陽股權投資管理企業(有限合夥)【已更名為福建融誠吾陽創業投資企業(有限合夥),以下簡稱“融誠吾陽”】、福建德潤壹號股權投資企業(有限合夥)(以下簡稱“德潤壹號”)合計持有公司IPO前股份591.63萬股,佔公司總股本6%。
融誠吾陽及德潤壹號近日通過大宗交易方式合計減持公司股份147.9萬股,佔公司總股本的1.50%。本次大宗交易減持完成後,融誠吾陽及德潤壹號合計持有443.73萬股,佔公司總股本4.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.